These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 7330975)

  • 1. Inhibition of the YC8 lymphoma growth by alloimmunization with normal cells.
    Parmiani G; Sensi ML
    Transplant Proc; 1981 Dec; 13(4):1906-9. PubMed ID: 7330975
    [No Abstract]   [Full Text] [Related]  

  • 2. Alloreactivity and tumor antigens: generation of syngeneic antilymphoma killer lymphocytes by alloimmunization of mice with normal cells.
    Sensi ML; Parenza M; Parmiani G
    J Natl Cancer Inst; 1983 Feb; 70(2):291-7. PubMed ID: 6571938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-associated alien alloantigens of BALB/c tumors encoded by the MHC and by non-H-2 genes: a histogenetic study.
    Parmiani G; Ballinari D; Sensi ML
    J Immunol; 1980 Feb; 124(2):662-8. PubMed ID: 6153203
    [No Abstract]   [Full Text] [Related]  

  • 4. Development of tumors as a result of graft-versus-host reaction.
    Cornelius EA
    Exp Hematol; 1973; 1(3):135-49. PubMed ID: 4153858
    [No Abstract]   [Full Text] [Related]  

  • 5. Variation in histocompatibility antigen expression on murine tumors: differences in expression and immunogenicity of H-2K region-coded unique antigens.
    Imamura M; Martin WJ
    J Immunol; 1982 Aug; 129(2):877-81. PubMed ID: 7086147
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of lymphoma growth in the spleen and liver of lethally irradiated mice.
    Iorio A; Campanile F; Neri M; Spreafico F; Goldin A; Bonmassar E
    J Immunol; 1978 May; 120(5):1679-85. PubMed ID: 659871
    [No Abstract]   [Full Text] [Related]  

  • 7. Mouse skin allograft model for study of pregraft blood transfusion.
    Maki T; Okazaki H; Wood ML; Monaco AP
    Transplant Proc; 1982 Jun; 14(2):394-6. PubMed ID: 7051485
    [No Abstract]   [Full Text] [Related]  

  • 8. Characterization of "foreign" alloantigen-like specificities on a murine lymphoma cell line.
    Finke JH; Fyfe DA; Del Villano BC; Butler GH; Ponzio NM
    Transplant Proc; 1980 Mar; 12(1):53-8. PubMed ID: 6154359
    [No Abstract]   [Full Text] [Related]  

  • 9. Mouse brain: an immunologically privileged site for natural resistance against lymphoma cells.
    Circolo A; Bianchi R; Nardelli B; Rivosecchi-Merletti P; Bonmassar E
    J Immunol; 1982 Feb; 128(2):556-62. PubMed ID: 7054288
    [No Abstract]   [Full Text] [Related]  

  • 10. Anti-thymocyte autoimmunity in BALB/C mice accompanying immunization to a syngeneic lymphoma.
    Baechtel FS; Prager MD
    J Immunol; 1977 Jan; 118(1):175-9. PubMed ID: 299754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Foreign H-2-like alloantigens of syngeneic tumor cells can act as new "restriction" molecules for the associative recognition of non-H-2 or tumor-associated antigens by lymphoid effectors in the cytostasis assay.
    Festenstein H; de Giorgi L; Matossian-Rogers A
    Transplant Proc; 1981 Dec; 13(4):1877-9. PubMed ID: 7330973
    [No Abstract]   [Full Text] [Related]  

  • 12. Analysis of the cellular immune response to and adoptive immunotherapy of a BALB/c lymphoma that cross-reacts with normal DBA/2 cells.
    Sensi M; Grazioli L; Parmiani G
    Cancer Immunol Immunother; 1986; 21(3):199-204. PubMed ID: 2938737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Depressed lymphoproliferative response in mixed leukocyte reaction after Mis-locus alloimmunization.
    Solana R; Alonso MC; de la Fuente M; Paniagua JA; Rojas R; Peña J
    Rev Esp Fisiol; 1984 Mar; 40(1):1-4. PubMed ID: 6235554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors related to therapeutic efficacy in adoptive chemoimmunotherapy of a Friend virus-induced lymphoma.
    Fass L; Fefer A
    Cancer Res; 1972 Nov; 32(11):2427-31. PubMed ID: 5082591
    [No Abstract]   [Full Text] [Related]  

  • 15. Cell-mediated cytotoxic responses induced in vivo and in vitro by a metastatic murine tumor.
    Wiltrout RH; Frost P
    J Immunol; 1980 May; 124(5):2254-63. PubMed ID: 7365255
    [No Abstract]   [Full Text] [Related]  

  • 16. Cross-reactions between tumor cells and allogeneic normal tissues. Inhibition of a syngeneic lymphoma outgrowth in H-2 and non-H-2 alloimmune BALB/c mice.
    Parmiani G; Sensi ML; Carbone G; Colombo M; Pierotti M; Ballinari D; Hilgers J; Hilkens J
    Int J Cancer; 1982 Mar; 29(3):323-32. PubMed ID: 7068280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. H-2 restriction of the T cell response to chemically induced tumors: evidence from F1 replaced by parent chimeras.
    Lannin DR; Yu S; McKhann CF
    J Immunol; 1982 Jan; 128(1):263-8. PubMed ID: 6459368
    [No Abstract]   [Full Text] [Related]  

  • 18. [Increase of the GvH reaction after alloimmunization. Influence of the serologically defined determinants of the H-2 system].
    Brock J; Siegl E; Schulze HA
    Allerg Immunol (Leipz); 1982; 28(2):91-6. PubMed ID: 6182783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alloimmunization and adoptive immunotherapy of leukemia.
    Truitt RL; Shih CY; Rimm AA; Tempelis LD; Bortin MM
    Transplant Proc; 1981 Dec; 13(4):1910-4. PubMed ID: 6949385
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of a Moloney lymphoma with cyclophosphamide and H-2-incompatible spleen cells.
    Fefer A
    Cancer Res; 1973 Apr; 33(4):641-4. PubMed ID: 4696464
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.